Health workers are really concerned about the intimidating tendencies around the growing of gonorrhea into a deadly and an untreatable infection in the turn of time. They noted that the bug has been developing resistance to antibiotics, fearing that one day, there wont be any remedy to treat it.
According to medical information on Wikipedia, “Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhea . As for men, they “may have burning with urination, discharge from the penis, or testicular pain.” As for Women, they “may have burning with urination, vaginal discharge, vaginal bleeding between periods, or pelvic pain. It is added that “Complications in women include pelvic inflammatory disease and in men include inflammation of the epididymis. And that “if untreated, gonorrhea can spread to joints or heart valves.”
Therefore, finding a remedy to gonorrhea is especially a matter of concern as it required expertise, time and advanced research to formulate new drugs. Confirming this, WHO Expert, Dr. Teodora Wi, said if the world must succeed in fighting Gonorrhea, then whatever remedy that must treat the disease must be in the laboratory by now.
“Gonorrhea is a very smart bug. Every time you introduce a new class of antibiotics to treat gonorrhea, the bug becomes resistant.
“It will only be a matter of years and this antibiotic will not be useful any more. It takes years to develop new drugs so we need to have that new drug in the pipeline so that in a few years’ time, we have something to replace the current treatment.”
As Experts describe gonorrhea has a “Super Bug”, Dr. Teodora Wi expresses worry over it spread and detection, especially in poor countries.
“Worryingly, the vast majority of infections are in poor countries where resistance is harder to detect – these cases may just be the tip of the iceberg,” She noted.
According to a report on the Telegraph News website, it is stated that “Manica Balasegaram, director of the Global Antibiotic Research and Development Partnership, said the situation was “grim” and there was a “pressing need” for new medicines.”
“We urgently need to seize the opportunities we have with existing drugs and candidates in the pipeline. Any new treatment developed should be accessible to everyone who needs it, while ensuring it is used appropriately, so that drug resistance is slowed as much as possible,” the Director advised.
